NIH Clinical Center Search the Studies: Study Number, Study Title

Protocol Details

Fasting Hypoglycemia: Diagnosis and Treatment

This study is currently recruiting participants.

Summary | Eligibility | Citations | Contacts

Summary

Number

91-DK-0066

Sponsoring Institute

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Recruitment Detail

Type: Participants currently recruited/enrolled
Gender: Male & Female
Min Age: 18
Max Age: N/A

Referral Letter Required

No

Population Exclusion(s)

Children;
Pregnant Women and Fetuses

Special Instructions

Currently Not Provided

Keywords

Hypoglycemia;
Insulinoma

Recruitment Keyword(s)

None

Condition(s)

Hypoglycemia;
Insulinoma

Investigational Drug(s)

None

Investigational Device(s)

None

Intervention(s)

None

Supporting Site

National Institute of Diabetes and Digestive and Kidney Diseases

Hypoglycemia is the term used to refer to lower than normal levels of blood sugar. This study will continue to research the causes of hypoglycemia.

Patients involved in the study will be admitted to the Clinical Center of the National Institutes of Health and undergo tests for evaluating blood sugar. Patients will be required to refrain from eating for a set period of time and will undergo blood tests for insulin levels and several other specific diagnostic tests related to insulin secretion. The patients will be under supervision and will be provided with appropriate medical and surgical attention as needed.

--Back to Top--

Eligibility

INCLUSION CRITERIA:

In order to be eligible to participate in this study, an individual must meet all of the following criteria:

1. Male, females ages >= 18.

2. Patients with documented fasting blood glucose below 55 mg/dl.

4. Patients with biochemical evidence for insulinoma or other neuroendocrine tumors.

EXCLUSION CRITERIA:

An individual who meets any of the following criteria will be excluded from participation in this study:

1. Patients with known sulfa allergies and patients with significant cardiac disease will be excluded.

2. Subjects who are pregnant.

3. Medically unstable per the assessment of the PI.


--Back to Top--

Citations:

Insulin receptors in patients with insulinomas: changes in receptor affinity and concentration

Reactive hypoglycemia and insulin autoantibodies in drug-induced lupus erythematosis

Approach to hypoglycemia in adults

--Back to Top--

Contacts:

Principal Investigator

Referral Contact

For more information:

Ranganath Muniyappa, M.D.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
BG 10-CRC RM 6-3952
10 CENTER DR
BETHESDA MD 20814
(301) 451-7702
muniyapr@mail.nih.gov

Craig S. Cochran, R.N.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institutes of Health
Building 5
Room 1604
5 Center Drive
Bethesda, Maryland 20892
(301) 402-1880
craigc@bdg10.niddk.nih.gov

Office of Patient Recruitment
National Institutes of Health Clinical Center (CC)
Building 61, 10 Cloister Court
Bethesda, Maryland 20892
Toll Free: 1-800-411-1222
Local Phone: 301-451-4383
TTY: 1-866-411-1010
PRPL@cc.nih.gov

Clinical Trials Number:

NCT00001276

--Back to Top--